"I hate playing devil's advocate but would Merk/Pfizer sabotage or treat the Avelumab they supply IMU so that trial fails and they can buy IMU at a lower SP once results of trial are announced? Can BP be trusted to supply a quality product?"
It is a combination trial. They want their drug to work better, and with imu's drug it probably will and with no added safety concerns.
Great results will mean that the big pharma's drug will be more commercially viable. They would then probably acquire imu too if that happens imho.
Ann: Clinical Trial Supply Agreement with Merck KGaA and Pfizer, page-184
-
- There are more pages in this discussion • 69 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.9¢ |
Change
0.005(9.26%) |
Mkt cap ! $433.6M | |||
| Open | High | Low | Value | Volume |
| 5.5¢ | 5.9¢ | 5.4¢ | $1.489M | 25.99M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 35252 | 5.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 6.0¢ | 1753430 | 24 |
View Market Depth
| Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
| IMU (ASX) Chart |